The present study demonstrated that ERRα plays an oncogenic role and facilitates the proliferation and invasion of RCC cells, and knockdown or pharmaceutical inhibition of ERRα induced remarkable growth regression in RCC cells, and caused a decrease of vessel intensity in tumor tissues. This evidence concerns the gene ESRRA and renal cell carcinoma.